These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38079008)

  • 1. Asymptomatic orthostatic hypotension in synucleinopathies: to treat or not to treat?
    Lenka A; Lamotte G; Beach P
    Clin Auton Res; 2024 Feb; 34(1):25-29. PubMed ID: 38079008
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?
    Udow SJ; Robertson AD; MacIntosh BJ; Espay AJ; Rowe JB; Lang AE; Masellis M
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1311-1321. PubMed ID: 27613160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious Agents as Potential Drivers of α-Synucleinopathies.
    Linard M; Ravier A; Mougué L; Grgurina I; Boutillier AL; Foubert-Samier A; Blanc F; Helmer C
    Mov Disord; 2022 Mar; 37(3):464-477. PubMed ID: 35040520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.
    Leys F; Wenning GK; Fanciulli A
    Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy.
    Ayers JI; Lee J; Monteiro O; Woerman AL; Lazar AA; Condello C; Paras NA; Prusiner SB
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35115402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthostatic hypotension preceding dementia with Lewy bodies by over 15 years: a clinicopathologic case report.
    Longardner K; Dickson DW; Litvan I
    Clin Auton Res; 2020 Dec; 30(6):575-577. PubMed ID: 32939679
    [No Abstract]   [Full Text] [Related]  

  • 10. α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies.
    Graves NJ; Gambin Y; Sierecki E
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Synucleinopathies: Twenty Years On.
    Goedert M; Jakes R; Spillantini MG
    J Parkinsons Dis; 2017; 7(s1):S51-S69. PubMed ID: 28282814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic Dysfunction in the Synucleinopathies.
    Coon EA
    Semin Neurol; 2020 Oct; 40(5):492-501. PubMed ID: 32906169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of autophagic protein DEF8 in Lewy bodies.
    Tanaka MT; Miki Y; Bettencourt C; Ozaki T; Tanji K; Mori F; Kakita A; Wakabayashi K
    Biochem Biophys Res Commun; 2022 Oct; 623():170-175. PubMed ID: 35921708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
    Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
    Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies.
    Palermo G; Del Prete E; Bonuccelli U; Ceravolo R
    J Neurol; 2020 Dec; 267(12):3444-3456. PubMed ID: 32594302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.
    Goldstein DS; Isonaka R; Lamotte G; Kaufmann H
    Clin Auton Res; 2021 Dec; 31(6):677-684. PubMed ID: 34669076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ɑ-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences.
    Peelaerts W; Bousset L; Baekelandt V; Melki R
    Cell Tissue Res; 2018 Jul; 373(1):195-212. PubMed ID: 29704213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term trends in myocardial sympathetic innervation and function in synucleinopathies.
    Lamotte G; Holmes C; Wu T; Goldstein DS
    Parkinsonism Relat Disord; 2019 Oct; 67():27-33. PubMed ID: 31621602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.
    Nimmo JT; Verma A; Dodart JC; Wang CY; Savistchenko J; Melki R; Carare RO; Nicoll JAR
    Alzheimers Res Ther; 2020 Nov; 12(1):159. PubMed ID: 33256825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.